Breaking News

Neuway Pharma and Cobra Biologics Collaborate

To develop GMP grade engineered protein capsules manufacturing process

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contract development and manufacturing organization (CDMO) Cobra Biologics and Neuway Pharma, a biopharma company developing drugs for the treatment of severe orphan CNS diseases, will partner to develop a manufacturing process for the production of GMP grade material of engineered protein capsules (EPCs) using SF9 cells and subsequent baculovirus infection. The material will be used by Neuway for the conduct of GLP toxicity studies and initiation of clinical development in the treatment of Prog...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters